- ICH GCP
- Register voor klinische proeven in de VS.
- Klinische proef NCT04821518
The Use of Samsung Health and ECG M-Trace Base II Applications in the Secondary Prevention After Stroke
The Use of Samsung Health and ECG M-Trace Base II Applications for the Assessment of Exercise Tolerance as the Secondary Prevention in Patients After Brain Stroke
Studie Overzicht
Toestand
Gedetailleerde beschrijving
Studietype
Inschrijving (Werkelijk)
Contacten en locaties
Studie Locaties
-
-
-
Poznań, Polen, 61-545
- Department of Rehabilitation and Physiotherapy Rehabilitation,
-
-
Deelname Criteria
Geschiktheidscriteria
Leeftijden die in aanmerking komen voor studie
Accepteert gezonde vrijwilligers
Geslachten die in aanmerking komen voor studie
Bemonsteringsmethode
Studie Bevolking
The study group (post-stroke) consisted of 26 patients (mean age 54.9±7.1) in whom ischaemic stroke occurred within 14 days before the admission to the Clinical Department.
The control group was composed of 26 healthy (mean age 55.6±6.1) individuals recruited from the hospital staff who did not experience stroke.
Beschrijving
Inclusion criteria to the post-stroke group were as follows :
- occurrence of hemiparesis after the first episode of ischaemic stroke
- stroke confirmed in the diagnostic imaging records
- score >3 on Lovett's scale of muscle strength in the paretic limbs
- score above 15 in Barthel's scale of performance in activities of daily living
- score below 12 in the National Institutes of Health Stroke Scale (NIHSS)
- available complete medical records concerning the assessed risk factors of recurrent CVD event
- lack of concomitant pulmonary diseases including chronic obstructive pulmonary disease and bronchial asthma
Exclusion criteria from the post-stroke group were as follows:
- hemiparesis or tetraparesis following many episodes of stroke,
- lack of diagnostic imaging scans confirming the occurrence of stroke
- hospital stay at the Department of Neurological Rehabilitation for more than 14 days from the occurrence of stroke
- incomplete medical records concerning the assessed risk factors of recurrent CVD event
- score >3 on Lovett's scale of muscle strength in the paretic limbs
- score below 14 in Barthel's scale of performance in activities of daily living
- score above 13 in the NIHSS scale
- occurrence of factors limiting walking ability, such as diagnosed pulmonary diseases, unstable angina, severe valvular heart diseases, cardiomyopathy, musculoskeletal or autoimmune diseases.
Studie plan
Hoe is de studie opgezet?
Ontwerpdetails
Cohorten en interventies
Groep / Cohort |
|---|
|
The study group (post-stroke)
The study group consisted of 26 patients in whom ischaemic brain stroke occurred within 14 days before the admission to the Clinical Department, and were hospitalised at the Department of Neurological Rehabilitation of the Clinical Department of Rehabilitation in the Wiktor Dega Orthopaedic and Rehabilitation Clinical Hospital in Poznań
|
|
The control group
The control group was composed of 26 healthy individuals recruited from the hospital staff who did not experience stroke.
|
Wat meet het onderzoek?
Primaire uitkomstmaten
Uitkomstmaat |
Maatregel Beschrijving |
Tijdsspanne |
|---|---|---|
|
heart rate at rest
Tijdsspanne: baseline
|
heart rate per minute
|
baseline
|
|
heart rate at rest
Tijdsspanne: 3 weeks
|
heart rate per minute
|
3 weeks
|
|
heart rate after SMWT
Tijdsspanne: baseline
|
heart rate per minute
|
baseline
|
|
heart rate after SMWT
Tijdsspanne: 3 weeks
|
heart rate per minute
|
3 weeks
|
|
heart rate after SCT
Tijdsspanne: baseline
|
heart rate per minute
|
baseline
|
|
heart rate after SCT
Tijdsspanne: 3 weeks
|
heart rate per minute
|
3 weeks
|
|
heart rhythm at rest
Tijdsspanne: baseline
|
heart rhythm interpreting ECG (regular or irregular)
|
baseline
|
|
heart rhythm at rest
Tijdsspanne: 3 weeks
|
heart rhythm interpreting ECG (regular or irregular)
|
3 weeks
|
|
heart rhythm after SMWT
Tijdsspanne: baseline
|
heart rhythm interpreting ECG (regular or irregular)
|
baseline
|
|
heart rhythm after SMWT
Tijdsspanne: 3 weeks
|
heart rhythm interpreting ECG (regular or irregular)
|
3 weeks
|
|
heart rhythm after SCT
Tijdsspanne: baseline
|
heart rhythm interpreting ECG (regular or irregular)
|
baseline
|
|
heart rhythm after SCT
Tijdsspanne: 3 weeks
|
heart rhythm interpreting ECG (regular or irregular)
|
3 weeks
|
|
increased blood pressure at rest
Tijdsspanne: baseline
|
blood pressure value [mm/Hg]
|
baseline
|
|
increased blood pressure at rest
Tijdsspanne: 3 weeks
|
blood pressure value [mm/Hg]
|
3 weeks
|
|
increased blood pressure after SMWT
Tijdsspanne: baseline
|
blood pressure value [mm/Hg]
|
baseline
|
|
increased blood pressure after SMWT
Tijdsspanne: 3 weeks
|
blood pressure value [mm/Hg]
|
3 weeks
|
|
increased blood pressure after SCT
Tijdsspanne: baseline
|
blood pressure value [mm/Hg]
|
baseline
|
|
increased blood pressure after SCT
Tijdsspanne: 3 weeks
|
blood pressure value [mm/Hg]
|
3 weeks
|
|
Distance of walk after SMWT
Tijdsspanne: baseline
|
Distance (metres)
|
baseline
|
|
Distance of walk after SMWT
Tijdsspanne: 3 weeks
|
Distance (metres)
|
3 weeks
|
|
Distance of walk after SCT
Tijdsspanne: baseline
|
Distance (metres)
|
baseline
|
|
Distance of walk after SCT
Tijdsspanne: 3 weeks
|
Distance (metres)
|
3 weeks
|
|
Steps after SMWT
Tijdsspanne: baseline
|
Number of steps (number)
|
baseline
|
|
Steps after SMWT
Tijdsspanne: 3 weeks
|
Number of steps (number)
|
3 weeks
|
|
Steps after SCT
Tijdsspanne: baseline
|
Number of steps (number)
|
baseline
|
|
Steps after SCT
Tijdsspanne: 3 weeks
|
Number of steps (number)
|
3 weeks
|
|
Velocity of walk after SMWT
Tijdsspanne: baseline
|
Mean velocity (km/h)
|
baseline
|
|
Velocity of walk after SMWT
Tijdsspanne: 3 weeks
|
Mean velocity (km/h)
|
3 weeks
|
|
Velocity of walk after SCT
Tijdsspanne: baseline
|
Mean velocity (km/h)
|
baseline
|
|
Velocity of walk after SCT
Tijdsspanne: 3 weeks
|
Mean velocity (km/h)
|
3 weeks
|
Medewerkers en onderzoekers
Onderzoekers
- Hoofdonderzoeker: Ewa Chlebuś, Clinic Rehabilitation, University of Medical Sciences in Poznań
Publicaties en nuttige links
Studie record data
Bestudeer belangrijke data
Studie start (Werkelijk)
Primaire voltooiing (Werkelijk)
Studie voltooiing (Werkelijk)
Studieregistratiedata
Eerst ingediend
Eerst ingediend dat voldeed aan de QC-criteria
Eerst geplaatst (Werkelijk)
Updates van studierecords
Laatste update geplaatst (Werkelijk)
Laatste update ingediend die voldeed aan QC-criteria
Laatst geverifieerd
Meer informatie
Termen gerelateerd aan deze studie
Aanvullende relevante MeSH-voorwaarden
Andere studie-ID-nummers
- 1/2021
Informatie over medicijnen en apparaten, studiedocumenten
Bestudeert een door de Amerikaanse FDA gereguleerd geneesmiddel
Bestudeert een door de Amerikaanse FDA gereguleerd apparaatproduct
Deze informatie is zonder wijzigingen rechtstreeks van de website clinicaltrials.gov gehaald. Als u verzoeken heeft om uw onderzoeksgegevens te wijzigen, te verwijderen of bij te werken, neem dan contact op met register@clinicaltrials.gov. Zodra er een wijziging wordt doorgevoerd op clinicaltrials.gov, wordt deze ook automatisch bijgewerkt op onze website .